Basic Information
ID: ALA3131916
Type: Functional
Description: Antitumor activity against human CL1-5 cells xenografted in Balb/c nu/nu mouse assessed as subcutaneously implanted tumor growth inhibition at 10 mg/kg/day, ip administered 3 times per week measured 2 times per week for 28 days
Organism: Homo sapiens
Cell type: CL1-5
Activity Charts
Bioactivity
Activity Types for Assay ALA3131916
TGI
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 379.46 | 3.93 | 3.93 |